发明名称 Pharmaceutical formulation in the form of a capsule or a compressed tablet comprising efavirenz and process for its preparation
摘要 <p>Pharmaceutical formulation in the form of a capsule or a compressed tablet comprising a therapeutically effective amount of efavirenz and more than 10 % by weight of a disintegrant relative to the total dry weight of the pharmaceutical formulation. Preferred disintegrant is sodium starch glycolate. Method for producing pharmaceutical formulation in the form of a capsule or a compressed tablet comprising a therapeutically effective amount of efavirenz and more than 10 % by weight of sodium starch glycolate relative to the total dry weight of the pharmaceutical formulation which comprises (a) wet granulating efavirenz and sodium starch glycolate in a high-shear granulator using an aqueous solution of sodium lauryl sulfate; (b) drying the product of step (a); (c) milling the product of step (b); (d) dry blending the product of step (c) with sodium starch glycolate and additional pharmaceutically acceptable excipients; and (e) encapsulating or compressing into tablets the product of step (d).</p>
申请公布号 SK284655(B6) 申请公布日期 2005.08.04
申请号 SK20000001461 申请日期 1999.04.01
申请人 DUPONT PHARMACEUTICALS COMPANY 发明人 MAKOOI-MOREHEAD WILLIAM T.;BUEHLER JOHN D.;LANDMANN BRIAN R.
分类号 A61K9/16;A61K9/20;A61K9/48;A61K31/535;A61K31/536;A61K47/36;A61P31/18;(IPC1-7):A61K31/535 主分类号 A61K9/16
代理机构 代理人
主权项
地址